tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Simcere’s ENZESHU® and ENDOSTAR® Included in China’s National Reimbursement Drug List
Company AnnouncementsSimcere’s ENZESHU® and ENDOSTAR® Included in China’s National Reimbursement Drug List
31m ago
2096
Simcere Secures Exclusive License for Deuterated Remdesivir Hydrobromide
PremiumCompany Announcements
Simcere Secures Exclusive License for Deuterated Remdesivir Hydrobromide
5d ago
2096
Simcere Pharmaceutical Grants 15.4 Million RSUs to Key Personnel
PremiumCompany Announcements
Simcere Pharmaceutical Grants 15.4 Million RSUs to Key Personnel
6d ago
2096
Simcere Pharmaceutical Revises Annual Caps Amid Growing Demand
PremiumCompany Announcements
Simcere Pharmaceutical Revises Annual Caps Amid Growing Demand
2M ago
2096
Simcere Pharmaceutical Expands Through Strategic Acquisitions
PremiumCompany Announcements
Simcere Pharmaceutical Expands Through Strategic Acquisitions
3M ago
2096
Simcere Pharmaceutical Completes Share Placement and Subscription to Boost R&D
PremiumCompany AnnouncementsSimcere Pharmaceutical Completes Share Placement and Subscription to Boost R&D
3M ago
2096
Simcere Pharmaceutical’s SIM0609 Receives Clinical Trial Approval
Premium
Company Announcements
Simcere Pharmaceutical’s SIM0609 Receives Clinical Trial Approval
3M ago
2096
Simcere’s Pediatric Anti-Influenza Drug Gains Regulatory Nod
Premium
Company Announcements
Simcere’s Pediatric Anti-Influenza Drug Gains Regulatory Nod
3M ago
2096
Simcere Pharmaceutical Announces Share Placing and Subscription Agreement
PremiumCompany Announcements
Simcere Pharmaceutical Announces Share Placing and Subscription Agreement
3M ago
2096
Simcere Pharmaceutical Expands with Strategic Acquisitions
PremiumCompany Announcements
Simcere Pharmaceutical Expands with Strategic Acquisitions
3M ago
2096
Simcere Pharmaceutical Grants 675,000 RSUs to Employees
PremiumCompany Announcements
Simcere Pharmaceutical Grants 675,000 RSUs to Employees
4M ago
2096
Simcere Pharmaceutical Sees Strong Revenue Growth in H1 2025
PremiumCompany Announcements
Simcere Pharmaceutical Sees Strong Revenue Growth in H1 2025
4M ago
2096
Simcere Pharmaceutical Announces Share Repurchase Plan
PremiumCompany AnnouncementsSimcere Pharmaceutical Announces Share Repurchase Plan
4M ago
2096
Simcere Pharmaceutical Enhances Governance with New Nomination Committee
Premium
Company Announcements
Simcere Pharmaceutical Enhances Governance with New Nomination Committee
4M ago
2096
Simcere Pharmaceutical Schedules Board Meeting to Review Interim Results
Premium
Company Announcements
Simcere Pharmaceutical Schedules Board Meeting to Review Interim Results
4M ago
2096
Simcere’s Rademikibart NDA Accepted by China’s NMPA
PremiumCompany Announcements
Simcere’s Rademikibart NDA Accepted by China’s NMPA
5M ago
2096
Simcere’s ENZESHU® Gains Approval in China for Platinum-Resistant Ovarian Cancer
PremiumCompany Announcements
Simcere’s ENZESHU® Gains Approval in China for Platinum-Resistant Ovarian Cancer
5M ago
2096
Simcere Pharmaceutical Amends License Agreement with Idorsia
PremiumCompany Announcements
Simcere Pharmaceutical Amends License Agreement with Idorsia
6M ago
2096
Simcere’s QUVIVIQ® Gains Approval for Marketing in China
PremiumCompany Announcements
Simcere’s QUVIVIQ® Gains Approval for Marketing in China
6M ago
2096
Simcere Enters Strategic License Agreement with NextCure for Oncology Advancements
PremiumCompany AnnouncementsSimcere Enters Strategic License Agreement with NextCure for Oncology Advancements
6M ago
2096
Simcere Pharmaceutical Announces Final Dividend for 2024
Premium
Company Announcements
Simcere Pharmaceutical Announces Final Dividend for 2024
6M ago
2096
Simcere Pharmaceutical Concludes AGM with Key Resolutions Passed
Premium
Company Announcements
Simcere Pharmaceutical Concludes AGM with Key Resolutions Passed
6M ago
2096

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >